Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm
Latest Information Update: 28 Aug 2018
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Blepharospasm
- Focus Therapeutic Use
- Sponsors Hugel
Most Recent Events
- 28 Aug 2018 New trial record